1. Sodium orthovanadate exhibits anti-angiogenic, antiapoptotic and blood glucose-lowering effect on colon cancer associated with diabetes
   Kruti Patel et al, 2024, Cancer Chemotherapy and Pharmacology CrossRef
2. Integrated analysis highlights APC11 protein expression as a likely new independent predictive marker for colorectal cancer
   Youenn Drouet et al, 2018, Scientific Reports CrossRef
3. E‐cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models
   Jarle Bruun et al, 2022, Molecular Oncology CrossRef
4. Gold nanoparticles regulate tight junctions and improve cetuximab effect in colon cancer cells
   Fernanda Leve et al, 2019, Nanomedicine CrossRef
5. Gene of the month: E-cadherin (CDH1)
   Tamara M H Gall et al, 2013, Journal of Clinical Pathology CrossRef
6. Mucinous Colorectal Adenocarcinoma
   Abd AlRahman M. Foda et al, 2015, Applied Immunohistochemistry & Molecular Morphology CrossRef
7. Correlation Between E-cadherin Immunoexpression and Efficacy of First Line Platinum-Based Chemotherapy in Advanced High Grade Serous Ovarian Cancer
   Branka Petrić Miše et al, 2015, Pathology & Oncology Research CrossRef
8. ATM mutations and E-cadherin expression define sensitivity to EGFR-targeted therapy in colorectal cancer
   Anna-Lena Geißler et al, 2017, Oncotarget CrossRef
9. E-Cadherin in Colorectal Cancer: Relation to Chemosensitivity
   Irina Druzhkova et al, 2019, Clinical Colorectal Cancer CrossRef